Nasal Passage Surgery
In 2014, Dr. Nachlas successfully completed the United States first in-office computer guided balloon sinuplasty with minimally invasive removal of nasal and sinus polyps. This advanced sinus procedure was a landmark for the advancement of sinus surgery and the latest in many groundbreaking innovations of the past three decades. Minimally invasive sinus surgery techniques began at the Johns Hopkins Hospital in Baltimore in 1985. That year heralded the first ever American course on endoscopic sinus surgery. Dr. Nachlas, as Chief Resident of the Department of Otolaryngology/Head and Neck Surgery at Johns Hopkins that year, was one of three instructors for that course. For the first time, surgeons were able to fix diseased sinuses by clearing the blockage through small telescopes passed through the nose.
The subsequent years brought refinement and further advancements to this specialty. Dr. Nachlas had the first intranasal laser (KTP laser) transmitted into the nose by fine fiber-optics in the late 1980s. In 1992, the Boca Raton Outpatient Surgery and Laser Center (BROSLC), under Dr. Nachlas’s guidance, became the first center of its kind to develop stereotactically guided sinus surgery. At that time, BROSLC joined the University of Pennsylvania and the University of Pittsburgh as the third site in the country to develop this procedure. It is now standard of care throughout the world. Further microdebridement techniques were developed over the last half of that decade to make the procedures quicker, safer, and with less downtime.
The next major advance in the minimally invasive treatment of chronic sinusitis came with the advent of balloon sinuplasty in the first decade of this century.
Dr. Nachlas was a principal investigator in the studies that demonstrated the efficacy and safety of these procedures. He has lectured and taught extensively about them. His previous pioneering role in stereotactically guided sinus procedures and the rapidly evolving technology of balloon sinuplasty led to his being chosen by Medtronic Corporation to be the testing site for the initial in-office computer guided balloon sinuplasty and in-office computer guided balloon sinuplasty with minimally invasive removal of nasal and sinus polyps. Both of these procedures launched in 2014 and have now have become the standard of care for appropriate patients. In 2015, Dr. Nachlas was selected as a site for the in-office placement of a dissolvable sinus stent impregnated with mometasone. This procedure is an adjunct to polyp removal and is performed to decrease the likelihood of polyp recurrence in highly susceptible individuals.
Learn more about Dr. Nachlas’s state-of-the-art approach to minimally invasive sinus surgery.
*We respect your privacy